CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

Nature

Volumn 385, Issue 6617, 1997, Pages 645-647

  He, Jianglin ^a,b   Chen, Youzhi ^a   Farzan, Michael ^a   Choe, Hyeryun ^a,b   Ohagen, Asa ^a,b   Gartner, Suzanne ^c   Busciglio, Jorge ^b,d   Yang, Xiaoyu ^a,b   Hofmann, Wolfgang ^a,b   Newman, Walter ^e   Mackay, Charles R ^e   Sodroski, Joseph ^a,b   Gabuzda, Dana ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ARTICLE; BRAIN DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MICROGLIA; PRIORITY JOURNAL; TARGET CELL; VIRUS CELL INTERACTION;

ADULT; ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BRAIN; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CC; CYTOKINES; GENE PRODUCTS, ENV; HIV-1; HUMANS; LECTINS; LIGANDS; LUCIFERASES; MICROGLIA; PLANT LECTINS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, HIV;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 19244380883     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/385645a0     Document Type: Article

References (30)

1. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996).
2. Deng, H. K. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).
3. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673 (1996).
4. Alkahatib, G. et al. CC CK5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).
5. Choe, H. et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).
6. Doranz, B. J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine rceptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996).
7. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
8. Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996).
9. Price, R. W. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239, 586-591 (1988).
10. Watkins, B. A. et al. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249, 549-553 (1990).
11. Takahashi, K. et al. Ann. Neurol. 39, 705-711 (1996).
12. Ponath, P. et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183, 2437-2448 (1996).
13. Daugherty, B. L. et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183, 2349-2354 (1996).
14. Heath, H. et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. (in the press).
15. Harouse, J. M. et al. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63, 2527-2533 (1989).
16. Tornatore, C., Nath, A., Amemiya, K. & Major, E. O. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65, 6094-6100 (1991).
17. Korber, B. T. M. et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68, 7467-7481 (1994).
18. Power, C. et al. Demented and nondemented patients with AIDS differ in brain derived human immunodeficiency virus type 1 envelope sequences. J. Virol 68, 4643-4649 (1994).
19. Strizki, J. M. et al. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J. Virol. 70, 7654-7662 (1996).
20. Gartner, S. & Popovic, M. Macrophage tropism of HIV-1. AIDS Res. Hum. Retroviruses 6, 1017-1021 (1990).
21. Westervelt, P., Gendelman, H. E. & Ratner, L. Identification of a determinant within the human immunodeficiency virus surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl Acad. Sci. USA 88, 3097-3101 (1991).
22. Li, Y. et al. Complete nucleotide sequence genome organization and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 66, 6587-6600 (1992).
23. Collman, R. et al. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol 66, 7517-7521 (1992).
24. + T cells. Science 270, 1811-1815 (1995).
25. Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
26. Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 883-835 (1996).
27. O'Brien, W. A. et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside of the CD4-binding domain. Nature 348, 69-73 (1990).
28. Schmidtmayerova, H. et al. Human immunodeficiency virus type 1 infection alters chemokine β peptide expresison in human monocytes: implifications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl Acad. Sci. USA 93, 700-704 (1996).
29. Shi, B. et al. Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Invest. 98, 1979-1990 (1996).
30. He, J. & Landau, N. R. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. J. Virol. 69, 4587-4592 (1995).